The medication, typically used for weight loss or diabetes treatment, is showing promise curbing cravings for alcohol and ...

President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a ...

Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular ...

Several studies have served up tantalizing hints about the drugs’ potential cancer prevention benefits, but other results ...

WASHINGTON -- GLP-1 receptor agonist use for weight loss early in pregnancy was associated with a lower likelihood that ...

Mounting research suggests GLP-1 drugs, which are used to treat diabetes and obesity, may one day help people with alcohol ...

Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity ...

On April 30, 2026, the U.S. Food and Drug Administration announced that it is proposing to exclude semaglutide, tirzepatide, and liraglutide from ...

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and ...

The boost in GLP-1 usage means more people seeing these side effects, which in turn creates new demand for hair care products ...

A wave of new research is reshaping understanding of GLP-1 weight-loss drugs, linking them to effects ranging from pregnancy outcomes and brain health to potential cancer prevention and social stigma.

Ashley Graham has voiced concern that the surge in GLP-1 weight loss drug use marks a reversal for the body positivity movement she has long championed. Speaking to Marie Claire, she described the ...